mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
BRD-K85133207 |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
L-685458 |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.2 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
BRD-A71883111 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |